In Vitro Study of Sequential Fluconazole and Caspofungin Treatment against Candida albicans Biofilms
暂无分享,去创建一个
[1] P. van Dijck,et al. Activities of Systemically Administered Echinocandins against In Vivo Mature Candida albicans Biofilms Developed in a Rat Subcutaneous Model , 2013, Antimicrobial Agents and Chemotherapy.
[2] L. Cowen,et al. Hsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms , 2011, PLoS pathogens.
[3] L. Cowen,et al. Regulatory Circuitry Governing Fungal Development, Drug Resistance, and Disease , 2011, Microbiology and Molecular Reviews.
[4] J. Lopez-Ribot,et al. An easy and economical in vitro method for the formation of Candida albicans biofilms under continuous conditions of flow. , 2010, Virulence.
[5] Arturo Casadevall,et al. An insight into the antifungal pipeline: selected new molecules and beyond , 2010, Nature Reviews Drug Discovery.
[6] A. Zaas,et al. PKC Signaling Regulates Drug Resistance of the Fungal Pathogen Candida albicans via Circuitry Comprised of Mkc1, Calcineurin, and Hsp90 , 2010, PLoS pathogens.
[7] J. Köhler,et al. Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle , 2010, PLoS pathogens.
[8] Aimee K. Zaas,et al. Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin , 2009, PLoS pathogens.
[9] A. Zaas,et al. Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease , 2009, Proceedings of the National Academy of Sciences.
[10] L. Cowen,et al. Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance � , 2022 .
[11] J. Heitman,et al. Synergistic Effect of Calcineurin Inhibitors and Fluconazole against Candida albicans Biofilms , 2008, Antimicrobial Agents and Chemotherapy.
[12] J. Lopez-Ribot,et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing , 2008, Nature Protocols.
[13] Gordon Ramage,et al. Candida biofilms on implanted biomaterials: a clinically significant problem. , 2006, FEMS yeast research.
[14] S. Lindquist,et al. Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi , 2005, Science.
[15] C. Kumamoto. A contact-activated kinase signals Candida albicans invasive growth and biofilm development. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[16] R. Darouiche,et al. Candida Infections of Medical Devices , 2004, Clinical Microbiology Reviews.
[17] Gordon Ramage,et al. Antifungal Combinations against Candida albicans Biofilms In Vitro , 2003, Antimicrobial Agents and Chemotherapy.
[18] J. Graybill,et al. In Vitro Activity of Caspofungin against Candida albicans Biofilms , 2002, Antimicrobial Agents and Chemotherapy.
[19] B. Wickes,et al. In Vitro Pharmacodynamic Properties of Three Antifungal Agents against Preformed Candida albicans Biofilms Determined by Time-Kill Studies , 2002, Antimicrobial Agents and Chemotherapy.
[20] M. Ghannoum,et al. Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins , 2002, Antimicrobial Agents and Chemotherapy.
[21] J. Lopez-Ribot,et al. Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients , 2001, Antimicrobial Agents and Chemotherapy.
[22] B. Wickes,et al. Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicansBiofilms , 2001, Antimicrobial Agents and Chemotherapy.
[23] D. McClish,et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] C. Beck-Sague,et al. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. , 1993, The Journal of infectious diseases.
[25] W J Martone,et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. , 1991, The American journal of medicine.